Johannes van der Vliet

PROF.DR., (Principal Investigator)

19972019

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy of cancer immunotherapy: An umbrella review of meta-analyses of randomized controlled trials

Kim, J. Y., Lee, K. H., Eisenhut, M., van der Vliet, H. J., Kronbichler, A., Jeong, G. H., Shin, J. I. & Gamerith, G., 2019, In : Cancers. 11, 11, 1801.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus

Werter, I. M., Huijts, C. M., Lougheed, S. M., Hamberg, P., Polee, M. B., Tascilar, M., Los, M., Haanen, J. B. A. G., Helgason, H. H., Verheul, H. M., de Gruijl, T. D., van der Vliet, H. J. & Dutch WIN-O Consortium, 1 May 2019, In : Cancer Immunology, Immunotherapy. 68

Research output: Contribution to journalArticleAcademicpeer-review

Optimal treatment of opioid induced constipation in daily clinical practice - An observational study

Neefjes, E. C. W., van der Wijngaart, H., van der Vorst, M. J. D. L., ten Oever, D., van der Vliet, H. J., Beeker, A., Rhodius, C. A., van den Berg, H. P., Berkhof, J. & Verheul, H. M. W., 2019, In : BMC Palliative Care. 18, 1, 31.

Research output: Contribution to journalArticleAcademicpeer-review

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: Protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

Rovers, K. P., Bakkers, C., Simkens, G. A. A. M., Burger, J. W. A., Nienhuijs, S. W., Creemers, G-J. M., Thijs, A. M. J., Brandt-Kerkhof, A. R. M., Madsen, E. V. E., Ayez, N., de Boer, N. L., van Meerten, E., Tuynman, J. B., Kusters, M., Sluiter, N. R., Verheul, H. M. W., van der Vliet, H. J., Wiezer, M. J., Boerma, D., Wassenaar, E. C. E. & 39 others, Los, M., Hunting, C. B., Aalbers, A. G. J., Kok, N. F. M., Kuhlmann, K. F. D., Boot, H., Chalabi, M., Kruijff, S., Been, L. B., van Ginkel, R. J., de Groot, D. J. A., Fehrmann, R. S. N., de Wilt, J. H. W., Bremers, A. J. A., de Reuver, P. R., Radema, S. A., Herbschleb, K. H., van Grevenstein, W. M. U., Witkamp, A. J., Koopman, M., Haj Mohammad, N., van Duyn, E. B., Mastboom, W. J. B., Mekenkamp, L. J. M., Nederend, J., Lahaye, M. J., Snaebjornsson, P., Verhoef, C., van Laarhoven, H. W. M., Zwinderman, A. H., Bouma, J. M., Kranenburg, O., van 't Erve, I., Fijneman, R. J. A., Dijkgraaf, M. G. W., Hemmer, P. H. J., Punt, C. J. A., Tanis, P. J. & de Hingh, I. H. J. T., 25 Apr 2019, In : BMC Cancer. 19, 1, 390.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

Huijts, C. M., Werter, I. M., Lougheed, S. M., Goedegebuure, R. S., van Herpen, C. M., Hamberg, P., Tascilar, M., Haanen, J. B., Verheul, H. M., de Gruijl, T. D., van der Vliet, H. J. & Dutch WIN-O Consortium, Feb 2019, In : Cancer Immunology, Immunotherapy. 68, 2, p. 319-329

Research output: Contribution to journalArticleAcademicpeer-review

Open Access